Main competitors
Add to a list
1m. Revenue rev. 4m. EPS revision 4m. Revenue rev. 1y. EPS revision 1y. Revenue rev. Visibility Nbr of analysts
- 1
26
21
25
27
20
20
24
21
26
22
22
27
21
15
20
17
18
17
Average 21
Weighted average by Cap. 23
Other Pharmaceuticals